A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors

Clinical trial NCT07036185 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07036185
Sponsor: Shanghai Bao Pharmaceuticals Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Gastric/Gastroesophageal Junction Cancer Breast Cancer Colorectal Cancer Non-small Cell Lung Cancer (NSCLC)Bile Duct Cancer Head and Neck Squamous Cell Carcinoma

Start date: 2025-06-24
Primary completion: 2026-12-31
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.